// June 26, 2023
Complex generics: Are global regulators addressing the needs?
The development of generic versions of innovator medicines is a global public health need.
The development of generic versions of innovator medicines is a global public health need.
In the U.S. and around the world, quality standards developed by the U.S.
Quality should be built into the entire drug product lifecycle – including the manufacturing and
The quality of medicine and how it’s delivered to patients is fundamental to treating illness and